Sudarshan Pharma Industries (BOM:543828) Other Current Receivables: ₹0 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:543828 Sudarshan Pharma Industries Ltd BOM:543828
73 GF Score
Price ₹39.80
GF Value ₹24.99
Valuation Significantly Overvalued
! 10 Warning Signs
View Full Analysis

What is Sudarshan Pharma Industries Other Current Receivables?

Sudarshan Pharma Industries BOM:543828 +4.27% 73 Other Current Receivables is ₹0 Mil as of Jun. 2026. GuruFocus rates BOM:543828 with a GF Score™ of 73/100 and a GF Value™ of ₹24.99 (Significantly Overvalued). The stock has 10 warning signs investors should review.

Sudarshan Pharma Industries's Other Current Receivables for the quarter that ended in Jun. 2026 was ₹0 Mil.

Sudarshan Pharma Industries's annual Other Current Receivables declined from Mar. 2024 (₹77.16 Mil) to Mar. 2025 (₹40.52 Mil) and declined from Mar. 2025 (₹40.52 Mil) to Mar. 2026 (₹0.00 Mil).

Sudarshan Pharma Industries Other Current Receivables Related Terms

Sudarshan Pharma Industries Other Current Receivables Historical Data

* Premium members only.

The historical data trend for Sudarshan Pharma Industries's Other Current Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sudarshan Pharma Industries Other Current Receivables Chart

Sudarshan Pharma Industries Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Other Current Receivables
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.69 114.79 77.16 40.52 0.00

Sudarshan Pharma Industries Quarterly Data
Mar17 Mar18 Mar19 Mar20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Other Current Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
BOM:543828
73GF Score
Sudarshan Pharma Industries Ltd BOM:543828
Other Current Receivables is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Sudarshan Pharma Industries Other Current Receivables Calculation

GuruFocus uses a standardized financial statement format for all companies. GuruFocus lists Accounts Receivable, Notes Receivable , Loans Receivable and Other Current Receivables under the "Total Receivables" section.

What does a Other Current Receivables of ₹0 Mil mean?
Sudarshan Pharma Industries (BOM:543828) has a Other Current Receivables of ₹0 Mil as of Jun. 2026. Other Current Receivables is other current receivables of that not otherwise classified. View historical data on Sudarshan Pharma Industries and its competitors.
Is Sudarshan Pharma Industries' Other Current Receivables too high?
Sudarshan Pharma Industries' current Other Current Receivables is ₹0 Mil. Overall, Sudarshan Pharma Industries has a GF Score™ of 73/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Sudarshan Pharma Industries' Other Current Receivables compare to DOW?
Sudarshan Pharma Industries' Other Current Receivables of ₹0 Mil can be compared against companies in the Chemicals industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Receivables for a Chemicals company?
A good Other Current Receivables depends on the Chemicals industry context. However, Other Current Receivables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Receivables mean?
A high Other Current Receivables can signal that a stock is expensive relative to its fundamentals. Other Current Receivables is other current receivables of that not otherwise classified. View historical data on Sudarshan Pharma Industries and its competitors. Sudarshan Pharma Industries's current Other Current Receivables is ₹0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sudarshan Pharma Industries stock overvalued right now?
Based on GuruFocus' analysis, Sudarshan Pharma Industries (BOM:543828) is currently considered Significantly Overvalued. The stock's GF Value™ is ₹24.99, compared to a current price of ₹39.80 — trading 59.3% above its estimated fair value. The current Other Current Receivables is ₹0 Mil. Sudarshan Pharma Industries' overall GF Score™ is 73/100 with 10 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Receivables calculated?
Other Current Receivables is calculated from a company's financial statements. For Sudarshan Pharma Industries (BOM:543828), the current Other Current Receivables is ₹0 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Sudarshan Pharma Industries (BOM:543828) Overvalued in 2026?

Based on GuruFocus' analysis, Sudarshan Pharma Industries stock appears to be overvalued. The current stock price of ₹39.80 is trading 59.3% above its estimated GF Value™ of ₹24.99. GuruFocus considers Sudarshan Pharma Industries to be Significantly Overvalued.

Key valuation signals for BOM:543828:

  • Other Current Receivables: ₹0 Mil
  • GF Value™: ₹24.99 vs. price of ₹39.80 (59.3% above fair value)
  • GF Score™: 73/100 with 10 warning signs

No single metric tells the full story. See the BOM:543828 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Sudarshan Pharma Industries Business Description

Address S V Road, 301, 3rd Floor, Aura Biplex, Above Kalyan Jewellers, Borivali (West), Mumbai, MH, IND, 400092
Sudarshan Pharma Industries Ltd operates in the pharmaceutical and chemical industries, focusing on specialty chemicals and intermediates used in pharmaceuticals, paints, food products, and adhesives. The Company has a presence domestically and internationally, participating regularly in trade fairs and exhibitions. The Company exports mainly to South East Asia, the Middle East, and North Africa. The Company also supplies generic pharmaceutical formulation as 'Make to order' for bulk supply to hospitals and related healthcare organisations. The company has one reportable segment of Specialty Chemicals.
73GF Score

Get the complete analysis for BOM:543828

Other Current Receivables is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹39.80
Price
₹24.99
GF Value